da Silva Filipe, A. et al. (2017) Response to DAA therapy in the NHS England early access programme for rare HCV subtypes from low and middle income countries. Journal of Hepatology, 67(6), pp. 1348-1350. (doi: 10.1016/j.jhep.2017.06.035) (PMID:28789880)
|
Text
146263.pdf - Accepted Version 550kB |
Abstract
No abstract available.
Item Type: | Articles (Letter) |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Aranday-Cortes, Dr Elihu and Da Silva Filipe, Dr Ana and Hughes, Dr Joseph and Vattipally, Dr Sreenu and Thomson, Professor Emma and McLauchlan, Professor John |
Authors: | da Silva Filipe, A., Sreenu, V., Hughes, J., Aranday-Cortes, E., Irving, W. L., Foster, G. R., Agarwal, K., Rosenberg, W., Macdonald, D., Richardson, P., Aldersley, M. A., Wiselka, M., Ustianowski, A., McLauchlan, J., and Thomson, E. C. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research |
Journal Name: | Journal of Hepatology |
Publisher: | Elsevier |
ISSN: | 0168-8278 |
ISSN (Online): | 1600-0641 |
Published Online: | 05 August 2017 |
Copyright Holders: | Copyright © 2017 Crown Copyright |
First Published: | First published in Journal of Hepatology 67(6): 1348-1350 |
Publisher Policy: | Reproduced in accordance with the publisher copyright policy |
University Staff: Request a correction | Enlighten Editors: Update this record